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Abstract
The passage of leukocytes across the endothelium and into arterial walls is a critical step in the development of
atherosclerosis. Previously, we showed in vitro that the RhoG guanine nucleotide exchange factor SGEF (Arhgef26)
contributes to the formation of ICAM-1-induced endothelial docking structures that facilitate leukocyte transendothelial
migration. To further explore the in vivo role of this protein during inflammation, we generated SGEF-deficient mice. When
crossed with ApoE null mice and fed a Western diet, mice lacking SGEF showed a significant decrease in the formation of
atherosclerosis in multiple aortic areas. A fluorescent biosensor revealed local activation of RhoG around bead-clustered
ICAM-1 in mouse aortic endothelial cells. Notably, this activation was decreased in cells from SGEF-deficient aortas
compared to wild type. In addition, scanning electron microscopy of intimal surfaces of SGEF2/2 mouse aortas revealed
reduced docking structures around beads that were coated with ICAM-1 antibody. Similarly, under conditions of flow, these
beads adhered less stably to the luminal surface of carotid arteries from SGEF2/2 mice. Taken together, these results show
for the first time that a Rho-GEF, namely SGEF, contributes to the formation of atherosclerosis by promoting endothelial
docking structures and thereby retention of leukocytes at athero-prone sites of inflammation experiencing high shear flow.
SGEF may therefore provide a novel therapeutic target for inhibiting the development of atherosclerosis.
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Introduction
Atherosclerosis is characterized by the successive influx of pro-
inflammatory monocytes and lymphocytes into the arterial wall
resulting in localized inflammation, accumulation of lipids, fibrosis
and cell death. These regions of local thickening are known as
atherosclerotic plaques [1]. ICAM-1 is a prominent endothelial
cell surface receptor for leukocyte recruitment and studies in mice
have shown that interfering with the function of this receptor
reduces the formation of atherosclerotic lesions [2–4]. Previously,
we found that ICAM-1 clustering on endothelial cells relocates the
Rho guanine nucleotide exchange factor (GEF) SGEF (Arhgef-26)
to the plasma membrane where it leads to activation of the Rho
family GTPase RhoG [5]. Subsequently, RhoG activation
contributes to the formation of actin rich protrusions on the
dorsal surface of endothelial cells [5], known as transmigratory
cups or docking structures [6;7]. These cups are thought to serve
as intermediate docking structures that provide mechanical
support for adhered leukocytes before transmigration (reviewed
in [8;9]). However, it is not known if these structures are involved
in pathology such as atherosclerosis. Also, whether Rho-GEFs in
general are involved in this process is unclear. Using SGEF-
deficient and wildtype mice, we show here that SGEF contributes
to the progression of atherosclerosis. Examining the interaction of
beads coated with antibodies against ICAM-1, we find that
although initial adhesion of the beads to the walls of isolated
arteries is identical in the SGEF null mice, exposure to flow
dislodges more beads from SGEF null than from wildtype arteries.
Consistent with these results, the SGEF null vessels and
endothelial cells reveal lower RhoG activation and decreased
docking structure formation than their wildtype counterparts. Our
results suggest that the reduced formation of docking structure in
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mice lacking SGEF contributes to the decreased susceptibility of
these mice to develop atherosclerosis.
Results
Since silencing RhoG or SGEF respectively were shown to
reduce leukocyte transmigration in a tissue culture model [5], we
hypothesized that deficiency of SGEF in mice would also affect
inflammatory responses by interfering with the proper formation
of apical cup structures. To test this hypothesis, we generated a
mouse line deficient in SGEF. In vitro over-expression experiments
using a mutated SGEF expression construct indicated that deletion
of a cDNA stretch encoded by exons 4/5 of the murine SGEF
gene, resulted in a non-functional protein (Figure 1A). Based on
this, we generated mice that lack exons 4 and 5 of the mouse
SGEF gene (Figure 1B–D). Intercrossing of heterozygote animals
(SGEF+/2) resulted in all three possible genotypes, indicating that
SGEF deficiency did not have lethal consequences during
embryogenesis. Animals of all genotypes and gender are viable
and fertile and do not show differences in leukocyte counts
(Table S1) or other obvious phenotypes (followed up to 18 months
of age). Genotype ratios of offspring after crossing SGEF+/2
animals matched the expected Mendelian distribution and did not
suggest an embryonic lethal phenotype (Figure S1). RT-PCR
analysis showed that mutated SGEF mRNA isolated from
SGEF2/2 mice was still detectable (Figure 2A). However,
sequencing and expression of the SGEF cDNA cloned from
SGEF2/2 mice showed that the introduced mutation led to a
frame shift proximal to the DH domain, resulting in the expression
of a protein fragment that lacked GEF activity. This was
confirmed by immunofluorescence experiments that showed that
SGEF-D4/5 did not induce typical dorsal ruffles, whereas the full
length construct did, as was also shown previously by our group
[10] (Figure 2B). Also biochemical studies showed that SGEF-D4/
5 was unable to activate endogenous RhoG, whereas full length
SGEF did (Figure 2C). Furthermore, when using a polyclonal anti-
SGEF antibody directed to the N-terminus that recognizes the
mutated form of SGEF expressed exogenously by HeLa cells, we
did not detect any SGEF protein fragment in Western blots of
organ lysates from SGEF2/2 mice (Figure 2D). These data show
that mutated SGEF mRNA is subject either to nonsense mRNA-
mediated decay or that any expressed truncated SGEF protein is
highly unstable. Taken together, deletion of exons 4/5 of the
SGEF gene resulted in animals that are completely devoid of any
functional SGEF protein.
Leukocyte recruitment and transmigration through the endo-
thelial cell layer into the vessel wall is a key step for the formation
of atherosclerotic lesions [11–13]. Because ICAM-1 deficiency was
previously found to protect from atherosclerosis in mice [2–4] and
because SGEF acts downstream of ICAM-1 to facilitate the
formation of docking-structures on endothelial cells [5], we sought
to investigate the role of SGEF in a mouse atherosclerosis model.
We generated experimental groups of SGEF+/+ApoE2/2 and
SGEF2/2ApoE2/2 mice (Figure 3A). SGEF+/+ApoE2/2 and
SGEF2/2ApoE2/2 did not exhibit differences in total body mass
or blood pressure (Figure 3B and Table S2). Upon feeding a
Western Diet (i.e. high fat and high cholesterol) for 14 weeks post-
weaning, the control SGEF+/+ApoE2/2 mice developed promi-
nent atherosclerotic plaques in their aortas, as measured by Oil
Red O (ORO) staining. Under these same conditions, the areas of
the ORO stained plaques were significantly smaller in SGEF2/
2ApoE2/2 compared to SGEF+/+ApoE2/2 mice (Figure 4A–D).
The decrease was observed in both the inner curvature of the
aortic arch (area of ORO staining in SGEF2/2ApoE2/2 was
decreased 45% of the area in the SGEF+/+ApoE2/2 aortas) and
the descending thoracic aorta (area of ORO staining in SGEF2/
2ApoE2/2 was decreased 66% of the area in the SGEF+/
+ApoE2/2 aortas). Furthermore, immunohistochemical analysis
showed that infiltrating CD68-positive macrophages were reduced
in plaques of SGEF2/2ApoE2/2 mice (Figure 4E). Importantly,
total body mass, triglyceride and cholesterol levels did not differ
between the two experimental groups (Figure S2A–C). In parallel
experiments, we measured the percentage of ORO stained areas
when the atherosclerotic stimulus was reduced by feeding a regular
chow diet instead of a Western Diet. Under these conditions, we
observed a slight reduction of stained plaque areas in SGEF2/
2ApoE2/2 compared to SGEF+/+ApoE2/2. For the inner
curvature of the aortic arch, the plaque area in SGEF2/
2ApoE2/2 was reduced by 31% compared to the plaque area
in SGEF+/+ApoE2/2 aortas. In the thoracic descending aorta, the
plaque area in SGEF2/2ApoE2/2 was reduced by 14%
compared to the SGEF+/+ApoE2/2 aortas (Figure 5A–B).
However, the reduction under this dietary condition was not
statistically significant. Therefore, these data indicate that SGEF
deficiency had most impact on the development of atherosclerosis
when animals were exposed to a diet containing high cholesterol
and high fat. It is noteworthy that studies on the influence of
ICAM-1 deficiency during atherosclerosis in mice similarly found
that certain experimental conditions (specifics of the diet, mouse
background strain, age of study animals) did not result in
significant plaque reductions [2;13].
To study if SGEF expression in hematopoietic cells, we isolated
these cells from wildtype animals and permeabilized them to
Figure 1. Generation of SGEF-deficient mice. A: HeLa cells were transfected with myc-tagged full-length SGEF (a) or mutated SGEF (Dexon4/5)
(b). SGEF was stained with an anti-myc Ab (red) and F-actin was visualized in green using Phalloidin. In the left panel, three positive cells in red are
shown; in the right panel, one positive cell in red is shown. Bar: 10 mm. B: Schematic presentation of the murine SGEF protein (a) and gene (b).
Domain structure of SGEF protein and genomic structure of the SGEF gene are shown according to the database. Latin numbers indicate exon
numbers. Roman numbers indicate the last and first codon position of each exon, respectively. (c) Enlarged area of exons 4/5. Numbers represent base
pairs counted from 10 kB upstream of exon 4. The positions of cutting sites for selected DNA-endonucleases are indicated. The locations of the
external probes P1 and P3 and the internal probe P4 are indicated as bars. (d) Schematic representation of the targeting vector. Filled triangles
represent loxP sites; open triangles represent frt sites. Framed DNA-endonuclease recognition sites were introduced into the genomic DNA by the
targeting construct. An endogenous ApaI site (at 9378) was destroyed by homologous recombination with the targeting construct and served to
detect homologous integration of the construct. C: Identification of successfully targeted ES-cell clones. After transfecting ES-cells with the targeting
construct and neomycin/ganciclovir selection, Southern blotting was performed with DNA from selected ES cell clones using the indicated
endonucleases. The binding sites of the probes used (P1 and P3) were located externally on both sides of the genomic area covered by the targeting
construct. The diagram at the top shows the location of the endonuclease recognition sites and the probes in the wild type allele and the
recombined allele, respectively. ES cell clones B11 and 2F10 were selected and used for subsequent steps. D: Identification of successful deletion of
exons 4/5. Southern blotting was performed with DNA from ES cell clones isolated after cre-transfection. The used probe P4 was located internally
within the genomic area covered by the short arm of the targeting construct. The diagram at the top shows the location of the endonuclease
recognition-sites and the probe P4 in wild type, targeted and cre-deleted alleles.
doi:10.1371/journal.pone.0055202.g001
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measure SGEF expression intracellularly using flow cytometry,
since the limited number of cells did not allow us to quantify SGEF
expression with Western blotting. We used isotype control
antibodies as well as the SGEF-deficient leukocytes as threshold
for the SGEF antibody staining. The data showed that SGEF was
not expressed in murine hematopoietic cells, indicating that other
cells were responsible for the reduced plaque formation in SGEF-
deficient animals (Figure S3). Our previous work showed that
RhoG is a major target of SGEF and mediates the formation of
dorsal ruffles [10]. Additionally, our group showed that RhoG
activation and formation of endothelial docking structures after
ICAM-1 clustering was reduced when SGEF was silenced [5].
Therefore, we determined if RhoG activation upon ICAM-1
clustering was perturbed in SGEF-deficient murine endothelial
cells. Primary cells from the intima of mouse aortas from SGEF+/+
and SGEF2/2 animals were isolated and subjected to magnetic
cell-sorting for ICAM-2 expression. When cultured on fibronectin-
coated surfaces, these cells (hereafter referred to as mouse aortic
endothelial cells, MAECs) formed monolayers of elongated cells
(Figure S4). Western blotting revealed that TNF-a-stimulated
MAECs expressed ICAM-1 and VE-Cadherin, whereas the
ICAM-2-negative cell population did not (Figure 6A), confirming
the endothelial identity of the isolated MAECs. Due to the limited
number of endothelial cells that can be isolated from mouse aortas,
biochemical pull down assays using GST-ELMO to measure
RhoG.GTP levels were not feasible. Therefore, through adeno-
viral delivery, YFP-tagged ELMO fragment was expressed in
MAECs. Since ELMO is a specific downstream effector of RhoG,
ELMO-YFP recruitment was measured as a read-out of local
RhoG activation, similar to what has been described for local
Rac1 activity upon phagocytosis [14]. TNF-a-stimulated primary
MAECs from wildtype and SGEF-deficient animals were overlaid
with polystyrene beads, coated with anti-ICAM-1 antibodies
(hereafter: anti-ICAM-1 beads). When anti-ICAM-1 beads
attached to the endothelium, time-lapse image acquisition was
started. A representative example of ELMO-YFP recruitment to
attached beads is shown in Figure 6B and supplemental movies
(Movie S1 and S2). Quantification revealed reduced recruitment
of ELMO-YFP to regions of attached beads in SGEF2/2 MAECs
compared to SGEF+/+ cells (Figure 6C). Significant reduction in
fluorescence intensity was measured in MAECs derived from
SGEF2/2 compared to MAECs from SGEF+/+ mice at all time
points between 0 and 60 minutes after bead attachment
(Figure 6D).
Our previous work showed that silencing of SGEF specifically
affected ICAM-1-mediated formation of docking structures
around adhered leukocytes [5]. Therefore, we examined if
SGEF-deficiency in mice decreased docking structure formation
on endothelial cells in situ. Aortas were isolated from SGEF+/+ and
SGEF2/2 mice as described in the Methods section and
stimulated with TNF-a overnight. Next, anti-ICAM-1 beads were
allowed to adhere to the endothelial surface of the aortas for
2 hours. Scanning electron microscopy (EM) analysis revealed that
the aortic intima, i.e. the endothelium, from wildtype animals
induced membrane protrusions around adherent beads, whereas
the aortic endothelium from SGEF2/2 animals showed minimal
protrusion activity in response to the beads (Figure 7A). Quan-
tification demonstrated that the percentage of anti-ICAM-1 beads
with membrane protrusions on their surface was significantly
decreased on aortas from SGEF2/2 animals compared to SGEF+/
+ aortas (SGEF+/+: 53.3614.8%; SGEF2/2: 37.3614.8%;
Figure 7B). Importantly, no differences were observed between
the genotypes when beads coated with anti-VCAM-1 or nonspe-
cific IgG1 antibodies were used (Figure S5A and S5B). When the
total number of anti-ICAM-1 beads that were attached to aortas
(independent of membrane protrusions) was counted, no differ-
ence in bead number between aortas isolated from SGEF+/+ and
SGEF2/2 animals was detected (Figure S5C).
These data indicated that adhesion to endothelial ICAM-1
under static conditions was not affected by SGEF-deficiency.
However, it has been proposed that docking structures provide
mechanical support for leukocytes to resist flow forces during
adhesion [15;16]. Therefore, anti-ICAM-1 beads were injected
into the lumen of isolated intact carotid arteries that were attached
to a perfusion system, as described in the Materials and Methods
section. Next, the arteries were continuously perfused with 5
dynes/cm2 for 5 minutes. Data from the literature shows that the
shear rates in arteries are usually 10 dynes/cm2 or more [17;18].
However, due to technical difficulties, we were unable to increase
the shear rate in the isolated arteries above 5 dynes/cm2.
Quantification analysis revealed that significantly lower number
of beads adhered to the inner surface of flow-exposed carotid
arteries from SGEF2/2 mice compared to SGEF+/+ mice
(SGEF+/+: 4.92 SD61.85, SGEF2/2: 0.63 SD60.41; Figure 7C).
Beads coated with an IgG1-isotype control antibody adhered very
poorly under flow conditions (Figure 7C). We wish to acknowledge
that our set-up did not allow the perfusion of isolated immune cells
over the arteries, due to firm adhesion of leukocytes to the inner
surface of the cannula, resulting in obstruction. Taken together,
these results showed that the formation of functional docking
structures upon ICAM-1 clustering is strongly reduced in SGEF-
deficient arteries.
Discussion
In this study, we have implicated a Rho GEF, SGEF, in the
formation of atherosclerosis in vivo. Our data show a significant
reduction in atherosclerotic lesions in the aortas of SGEF-deficient
mice when fed a Western diet. At the molecular level, we show
that SGEF-deficiency decreased RhoG activation and the
formation of docking structures in response to ICAM-1 clustering.
Rahaman and colleagues have shown that the Rho-GEF Vav1 is
involved in the formation of foam cells and thereby contributes to
the development of atherosclerosis [19]. To our knowledge, this is
the first description of an endothelial Rho GEF involved in the
formation of atherosclerosis. SGEF was targeted by deleting exon
4 and 5. Overexpressing this truncated form of the protein showed
no functionality. Moreover, using SGEF specific antibodies that
recognize the truncated form, we found that the mutant protein
was not translated in mice. Therefore, we concluded that the
SGEF deletion strategy resulted in mice that did not show any off-
target phenotypes.
Figure 2. Basic phenotyping of SGEF deficient mice. A: RT-PCR from mouse liver mRNA using primers which bind in exon 1 and in different
downstream exons of mouse SGEF as indicated. RT-PCR bands from SGEF2/2 animals marked with an asterisk are ,200 bp smaller compared to wild
type. B and C: SGEF ex1-14 cDNA cloned from RT-PCRs from SGEF+/+ and SGEF2/2 mice was over expressed in HeLa cells. The transfected HeLa cells
were analyzed for dorsal ruffle formation (arrowheads) (B) and the activity levels of RhoG (C). Graph at the right shows fold increase of Rho.GTP
loading upon transfection or treatment as indicated. This experiment was repeated 4 times. D: Expression of SGEF in different mouse tissues. The
polyclonal antibody used was raised against a 200 amino acid stretch at the N-terminus of murine SGEF.
doi:10.1371/journal.pone.0055202.g002
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Atherosclerosis is nowadays recognized as an inflammatory
disease [20]. Inflammation is characterized by activated leukocytes
that extravasate from the vessel into the underlying tissue. During
the development of atherosclerosis, this process occurs inappro-
priately [21]. Monocytes are the first immune cells that are
detected in early atherosclerotic lesions [1]. In this study, mice
deficient for SGEF in all cell types are generated. Therefore, the
reduced plaque areas that were detected in SGEF-deficient mice
Figure 3. Generating an SGEF-deficient and ApoE-deficient mouse model to examine development of atherosclerosis. A: Breeding
scheme to generate SGEF/ApoE double knock-out mice. Litter mates from breeding SGEF+/2ApoE2/2 mice were used in a pilot study (marked with
light grey). Animal groups highlighted in dark gray were used for all subsequent studies to characterize formation of atherosclerosis. B: Total body
mass of study animals at different ages. Error bars represent SEM.
doi:10.1371/journal.pone.0055202.g003
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could potentially also be the result of less infiltrated leukocytes, in
particular monocytes, due to the lack of SGEF in these cells. SGEF
is expressed in epithelial and endothelial cells [5;10] but we have
not detected in mouse monocytes or neutrophils. In previous work,
no expression was detected in HL60 and U937 cells [10]. These
cells are hematopoietic precursor cells for neutrophils and
monocytes, respectively. These data suggest that primary mono-
cytes and neutrophils are devoid of SGEF expression and indicate
that the decrease in atherosclerotic plaques in the SGEF-deficient
animals is due to the absence of SGEF in endothelial cells rather
than in monocytes.
Recent studies have shown that the endothelium actively
participates in the extravasation process by inducing docking
structures [5–7;21;22]. These are characterized by membrane
protrusions, also known as dorsal membrane ruffles that extend
from the apical surface of the endothelium. The small GTPases
Rac1 and in particular RhoG are recognized for their ability to
induce these type of membrane extension [10]. Also during
leukocyte binding to the endothelium, Rac1 and RhoG are
activated [23]. Our work indicated that reduction of RhoG
expression represses the ability of the endothelium to induce dorsal
ruffles and, as a consequence, also the formation of docking
structures around adherent leukocytes [23]. Additional experi-
ments indicate that the RhoG-specific Rho-GEF SGEF is
responsible for the GTP exchange on RhoG in these endothelial
cells during leukocyte adhesion and transmigration [5]. Our data
presented here show that endothelial cells from aortas that lack
SGEF compared with wildtype endothelial cells fail to induce these
typical docking structures. Notably, we found that the SGEF2/2
aortas were less able to retain beads coated with anti-ICAM-1
under conditions of flow. This is consistent with the docking
structures normally functioning to prevent leukocytes from being
Figure 4. Reduced atherosclerotic plaque formation in SGEF deficient mice fed a Western diet. SGEF+/+ApoE2/2 and SGEF2/2ApoE2/2
mice were fed a Western Diet for 14 weeks post-weaning (weaning at 3 weeks of age), before aortas were isolated and the plaque area was
determined by ORO staining. A: Representative en face images of ORO staining of the inner curvature of the aortic arches. B: Quantification of ORO-
stained area on inner curvature of the aortic arches from SGEF+/+ApoE2/2 and SGEF2/2ApoE2/2 (n = 10 per genotype; SGEF+/+ApoE2/2: 15.863.7%;
SGEF2/2ApoE2/2: 8.863.7%; Data are mean 6 SD. ***p,0.006. Bar graph at the right represents averaged measurements of all studied aortic arches.
Left graph shows the measured ORO-stained area of individual aortas (represented by diamonds). C and D: As described under A and B, but for the
descending thoracic aorta: D: Quantification of plaque area in the: SGEF+/+ApoE2/2: 3.261.9%; SGEF2/2ApoE2/2: 1.160.5%; Data are mean 6 SD.
***p,0.007. E: Histology samples were stained for CD68 or ICAM-1 as indicated to detect macrophage presence in plaque areas. Graph at the right
shows the quantification of CD68 positive areas in the plaque. n = 4. Asterisks indicate *p,0.05 according to Student T-test.
doi:10.1371/journal.pone.0055202.g004
Figure 5. Atherosclerotic plaque formation in mice fed a normal chow diet. A and B: SGEF+/+ApoE2/2 and SGEF2/2ApoE2/2 mice were fed
a chow diet for 16 weeks post weaning (weaning at 3 weeks of age), before aortas were isolated and the plaque area was determined by ORO
staining (n = 11 for SGEF+/+ApoE2/2 aortas; n = 9 for SGEF2/2ApoE2/2 aortas; Data are mean 6SEM; N.S.: not significant; p-values represent 2-tailed
Student’s T-test with unequal variance). A: Quantification of ORO-stained area of the inner curvature of the aortic arch. The bar graphs at the left
represent averaged measurements of all aortas. The right graph shows the measured ORO-stained area of individual aortas (represented by
diamonds). SGEF+/+ApoE2/2: 4.862.0%; SGEF2/2ApoE2/2: 3.362.0%; p,0.11. B: Same as described under A for thoracic descending aorta: B:
Descending thoracic aorta: SGEF+/+ApoE2/2: 0.860.4%; SGEF2/2ApoE2/2: 0.760.2%; p,0.43.
doi:10.1371/journal.pone.0055202.g005
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Figure 6. Defective activation of RhoG after ICAM-1 clustering on SGEF-deficient primary mouse aortic endothelial cells. A:
Molecular characterization of the ICAM-2-positive cell isolation. All cells (flow-through fraction (ICAM-2 negative) and ICAM-2 positive) were
stimulated with 10 ng/ml TNF-a for 4 hours prior to lysis for Western blotting as indicated. The ICAM-2-positive cells expressed ICAM-1 and VE-
cadherin, markers for endothelial cells. Also, SGEF expression was only measured in the isolates from wildtype animals and not from the knock-out.
Hereafter, the ICAM-2-positive cells are referred to as mouse aortic endothelial cells (MAECs). B: Representative time-lapse imaging of ELMO-YFP
recruitment to sites of adhesion of anti-ICAM-1-Ab coated beads on TNF-a-treated MAECs from SGEF+/+ or SGEF2/2 animals. Arrowheads show bead
location and only in the wildtype cells, ELMO recruitment is observed. Bar: 10 mm. C and D: Quantification of ELMO-YFP recruitment to adhered
beads. Fluorescence intensity was measured in regions of adherent beads on MAECs, isolated from SGEF+/+ and SGEF2/2 animals. Graph C shows
measurements at each time point. Data represent pooled results from 3 independent experiments. Graph D shows averaged fluorescent intensity at
time-points from 10 to 60 minutes after bead binding. Data represent pooled results from 3 independent experiments. Asterisks indicate ***p,0.05,
**p,0.005 or *p,0.0005 according to Student T-test.
doi:10.1371/journal.pone.0055202.g006
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washed away from regions of inflammation. Together, these data
indicate that the reduced lesion area in SGEF-deficient animals is
most likely due to the inability of the endothelium to induce
docking structures that actively retain leukocytes against the forces
of blood flow thereby assisting their crossing of the vessel wall.
Our data suggest that SGEF may be an attractive pharmaco-
logical target for decreasing atherosclerosis, since we have not
observed any negative phenotypes in mice that lack SGEF. An
SGEF-based pharmacological prevention strategy is further
supported by studies showing that ICAM-1 deficiency also results
in reduced atherosclerosis [2–4]. Therapies targeting ICAM-1 are
an interesting approach; however, adverse effects were found
when anti-ICAM-1 antibodies were used in a phase III clinical
study with ischemic stroke patients [24]. In general, antibody-
based therapies targeting cell surface receptors involve serious side
effects [25] and are less appropriate for long term applications
such as treatment of atherosclerosis. Additionally, ICAM-1 is
involved in acute host defense, and therefore increased suscepti-
bility to infectious organisms is an intrinsic side effect of targeting
this receptor [26]. Developing therapeutic drugs targeting SGEF
function may avoid these problems.
Materials and Methods
Mice
To build a targeting construct for the murine SGEF gene, the
pOSfrt-loxP vector was used (kindly provided by Dr. Oliver
Smithies and the UNC Animal Model Core Facility). Mouse
genomic areas were amplified by PCR. The short arm: (3039 bp,
starting 470 bp downstream of exon 5; ending 3509 bp down-
stream of exon 5) was cloned into the BamHI/NotI sites of the
vector. A double stranded oligo-nucleotide representing the second
LoxP site and an FseI site was introduced into the NheI/ClaI sites of
the construct. The DNA fragment of the genomic area covering
Exon 4/5 (4495, starting 624 bp upstream of exon 4 immediately
after a genomic ApaI site; ending 467 bp downstream of exon 5)
was cloned into the ClaI/FseI sites of the construct. Finally, the
long arm (5412 bp, starting 6042 bp upstream of exon 4; ending
630 bp upstream of exon 4 immediately before a genomic ApaI
site) was cloned via the NheI site of the construct and its orientation
was checked by sequencing. For ES cell transfection, the construct
was linearized by a NotI digest. ES cell transfections and blastocyst
injection were performed by the UNC Animal Model Core
Facility. ES cell clones that have integrated the construct into the
genome through homologous recombination of the short and long
arm were identified by Southern blotting. Two selected clones
were then transfected with an expression construct for cre-
recombinase to delete exon 4/5, which was again confirmed by
Southern blotting. These cells were used for blastocyst injection
and the mutated allele was crossed out by breeding chimeras with
wild type c57/black6 mice. Animals were crossed back to wild type
c57/black6 mice over at least 7 generations. Wildtype c57/black6
mice (strain: C57BL/6J) and ApoE-deficient mice (strain:
B6.129P2-ApoEtm1Unc/J) were obtained from Jackson Laboratories.
Atherosclerosis study mice were either fed a regular chow diet
(‘Prolab RMH3000’, LabDiet 6.4% fat, 195 ppm cholesterol) or a
high fat diet (‘Western Diet for Rodents’, Testdiet, 19.9% fat, 1707
Figure 7. Membrane protrusions of intimal endothelial cells
after ICAM-1 crosslinking. A: Isolated aortas from SGEF+/+ and
SGEF2/2 mice were mounted with the intimal site facing up. After TNF-
a treatment, the aortas were overlaid with anti-ICAM-1-Ab coated
beads for 2 hours, before unbound beads were washed off and imaged
by scanning electron microscopy. Representative scanning electron
microscopy show attached anti-ICAM-1-Ab coated beads to the intimal
surface of aortas from SGEF+/+ and SGEF2/2 animals. Right panels show
magnification of adherent bead. Scale bars represent 0.1 mm or 10 mm,
as indicated. B: Quantification of antibody coated beads that induced
membrane protrusions on aortas from SGEF+/+ and SGEF2/2 animals.
Anti-ICAM-1-Ab coated beads: SGEF+/+: 53.3614.8%; SGEF2/2:
37.3614.8%. Anti-VCAM-1-Ab coated beads: SGEF+/+: 25.868.9%;
SGEF2/2: 24.2610.0%. Anti-IgG1-Ab coated beads: SGEF+/+: 8.267.0%;
SGEF2/2: 7.569.3%. Data are mean 6SEM. ***p,0.001. C: Quantifica-
tion of total number of anti-ICAM-1-Ab or IgG1-Ab coated beads that
adhered to the intimal surfaces of isolated and intact carotid arteries
under flow conditions (5 dynes/cm2). Anti-ICAM-1-Ab coated beads:
SGEF+/+: 4.961.8; SGEF2/2: 0.660.4. Anti-IgG1-Ab coated beads: SGEF+/
+: 1.061.1; SGEF2/2: 0.860.6. Experiment was carried out at least 4
times. Data are mean 6SEM. ***p,0.001.
doi:10.1371/journal.pone.0055202.g007
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ppm cholesterol). Animals used in the atherosclerosis study were
all males. For the atherosclerosis study, animals were backcrossed
at least 7 times. For the isolated vessels, animals were backcrossed
at least 10 times. All animal experiments described here are
approved by the Institutional Animal Care and Use Committee of
the University of North Carolina (IACUC-ID: 06-145, 08-202, 09-
043) and the Local Ethical Committee of the University of
Amsterdam (NIH Publication No. 85–23, revised 1996).
Oil Red O (ORO) staining method
Mice were perfused with PBS followed by PBS/4% PFA.
Dissected aortas were further fixed for 48 hours in PBS/4% PFA.
After incubating the aortas in 75% ethanol the aortas were stained
with 0.5% Oil Red O (ORO)/60% isopropanol. Images were
taken of longitudinally opened aortas that were pinned down on
wax. Images were taken with dissection microscope and a color
camera. Percentage of ORO stained areas was determined with
ImageJ software.
Antibodies and Reagents
The following antibodies were used: mouse anti-RhoG (clone
1F3, Millipore); rat-anti-mouse-ICAM2 (clone 3C4, BD-Pharmin-
gen); rat-anti-mouse-ICAM1 (clone MAB796, R&D); mouse-anti-
VE-Cadherin (clone F8, Santa Cruz), anti-VCAM-1 mAb (R&D),
IgG1-isotype control Ab (Sanquin, Amsterdam, the Netherlands),
anti-Myc mAb (Clone 9E10; Sigma) and secondary HRP Abs
were from Dako (Denmark). Phalloidin-Alexa488 or Texas-red
was purchased from Invitrogen. Endothelial tissue culture media
EBM-2 (supplemented with EGM-2 SingleQuotsTM) was obtained
from Lonza. DMEM media was obtained from Gibco. The
following reagents were used: Oil Red O (Sigma); Heparin
(Abraxis, 10000 USP units/ml); magnetic beads coated with
sheep-anti-rat-IgG (Dynal); polystyrene beads ‘Amino Micro-
spheres’ (Polyscience 3.0 mm carotid artery perfusion, 5 mm for
biosensor experiments, 10 mm for aorta EM experiments). Proteins
were bound to polystyrene beads according to the manufacturer’s
protocol followed by free glutaraldehyde group blocking with 0.5
M ethanolamine and 2 mg/ml BSA.
Isolation of Mouse Aortic Endothelial Cells
Mouse aortic endothelial cells (MAECs) were isolated by
combining two modified protocols that have been described
previously [27;28]. Briefly, adult mice (8 to 12 weeks old) were
anesthetized and then perfused with PBS containing 20% FBS and
100 units heparin. The thoracic descending aorta was isolated
(from end of descending arch to diaphragm) and put into a glass
dish with the bottom covered with a layer of sterile wax. All
subsequent dissecting steps were done in this dish under DMEM
media. Remaining connecting tissue on the outside of the aorta
was removed before the aorta was opened by a longitudinal cut.
The opened aorta was pinned down with small needles with the
intimal surface facing up. After removing the media, the pinned
down aorta was overlaid with 0.5 ml of DMEM/Collagenase
(2 mg/ml) at 37uC for 60 minutes. Subsequently, continuous
flushing of the intima released the aortic endothelial cells which
were then plated on collagen-I coated dishes. After two days, the
cells were overlaid with magnetic Dynal beads that had been
coated with anti-ICAM2 antibody. After 30 minutes the cells were
trypsinized and sorted by a magnet, before the bead-bound cells
were again plated on Collagen-1 coated dishes and used for
experiments within the following 7 to 14 days.
Biosensor to Measure Local RhoG activation
To calculate local activation of RhoG in cells, a fluorescently
tagged fragment of ELMO1 was used (ELMO-Ypet). The cDNA
was cloned into pAd vector and adenovirus particles were
produced in 293A cells (‘ViralPower Adenoviral Expression
System’ from Invitrogen). Twenty-four hours post infection of
MAECs; time-lapsed image stacks were acquired. Fluorescence
was measured in a circular area (diameter 8.3 mm) around an
attached bead. Fluorescence right before bead attachment was
used as the baseline fluorescence.
Bead Adhesion Assay and Scanning Electron Microscopy
of Mouse Aortas
Murine aortas were dissected using microsurgery, cut open
longitudinally and kept overnight at 37uC at 5% CO2. In parallel,
the samples were pretreated with 10 ng/mL murine TNF-alpha
overnight. For scanning electron microscopy (scanning EM),
1 mg/ml of antibody-containing beads was washed and re-
suspended in EGM-2 medium. Next, the beads were incubated
on an isolated murine aorta for 2 hours as indicated. After the
appropriate time, unbound beads were removed, and samples
were put on ice, gently washed three times with ice-cold PBS
containing 1 mM Ca2+/Mg2+. Subsequently samples were fixed in
2.5% glutaraldehyde/PBS for 30 min at room temperature, and
processed for scanning electron microscopy as described previ-
ously 6. Cells were examined on a scanning electron microscope
(model 820; JEOL) at 15 kV. Scanning EM analysis revealed the
induction of docking structures as described in results section.
Perfusion assay
Specially-developed cannulae are placed on each end of an
isolated carotid artery and EGM-2 medium, containing anti-
ICAM-1 or IgG1-isotype Ab-coated beads, was added. Beads were
allowed to adhere for 30 minutes, followed by induction of flow at
5 dynes/cm2. After 5 minutes, arteries were fixed using 3.7%
formaldehyde, permeabilized using 0.2% Triton X-100, stained
for F-actin using Texas-Red Phalloidin and nuclei using DAPI and
analyzed by confocal laser scanning microscopy. Beads were
visualized using DIC. Tile scan (363) images were recorded with a
ZEISS LSM510 confocal microscope with appropriate filter
settings and the number of beads was counted per tile scan. At
least 3 tile scans were counted per experiment.
Statistical analysis
Statistical comparisons between experimental groups were
performed by the 2-tailed Student’s T-test with unequal variance.
A 2-tailed p-value of ,0.05 was considered significant.
Supporting Information
Figure S1 Observed genotype frequency of offspring
originating after breeding SGEF+/2 mice (134 pups from
20 litters, backcross generation $7).
(TIF)
Figure S2 Characterization of plasma samples from
study animals at the final age of animals 14 weeks post-
weaning. A: Total cholesterol levels in mg/dL in plasma. n = 5
per genotype. Data are mean 6SEM. B: Triglyceride levels in
mg/dL in plasma. n = 5 per genotype. Data are mean 6SEM. C:
Total body mass (grams) of male mice fed a Western Diet over 14
weeks. Closed line represents SGEF+/+ApoE2/2 animals; Dotted
line represents SGEF2/2ApoE2/2 animals. n = 5 per genotype.
(TIF)
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Figure S3 SGEF expression analysis in hematopoietic
cells. Hematopoietic cells were isolated from whole blood from
wildtype and SGEF-deficient mice and subsequently fixed and
permeabilized for intracellular staining. Cells were incubated
subsequently with SGEF polyclonal Ab (Proteintech Europe,
Manchester, UK) and secondary FITC-labeled Ab. The Ab
epitope of human SGEF, to which the Ab was directed, shows
98% homology with murine SGEF. Forward-side scatter plot
shows distribution of all cells. P1 region reflects immune cells and
show very few positive cells in both wildtype and SGEF-deficient
samples. Purple area reflects platelets, which were also negative for
SGEF staining in both conditions. Graph below shows the
quantification of mean fluorescent intensity (MFI) of intracellular
SGEF staining. Four animals were analyzed. Data are mean 6
SEM.
(TIF)
Figure S4 Phase microscopy images of isolated endo-
thelial monolayers. ICAM-2-positive cells were isolated from
the intimal side of the mouse aortas from SGEF+/+ and SGEF2/2
mice. The dark particles are ICAM-2-coated magnetic Dynal
beads that remained after cell sorting. Scale bar: 10 mm.
(TIF)
Figure S5 Membrane protrusions of intimal endothelial
cells after VCAM-1 clustering or control beads. A: Isolated
aortas from SGEF+/+ and SGEF2/2 mice were mounted with the
intimal site facing up. After TNF-a treatment, the aortas were
overlaid with anti-VCAM-1-Ab coated beads for 2 hours, before
unbound beads were washed off and imaged by scanning electron
microscopy. Representative scanning electron microscopy show
attached anti-VCAM-1-Ab coated beads to the intimal surface of
aortas from SGEF+/+ and SGEF2/2 animals. Right panels show
magnification of adherent bead. Scale bars represent 0.1 mm or
10 mm, as indicated. B: Same as described under A, but VCAM-1
beads were replaced by IgG1-isotype Ab coated beads. C:
Adhesion of anti-ICAM-1-Ab coated beads to the intimal surface
of aortas from SGEF+/+ and SGEF2/2 animals was similar under
static conditions. SGEF+/+: 16.766.9 beads per field, SGEF2/2:
15.466.8 beads per field. Data are mean 6SEM.
(TIF)
Table S1 Analysis of SGEF2/2 animals. Differential
leukocyte counts of male and female SGEF+/+ and SGEF2/2
mice (backcross generation $7).
(TIF)
Table S2 Intra aortic blood pressure measurements.
Animals were measured 19 weeks of age. 6 represents SD; N.S.:
not significant.
(TIF)
Movie S1 Movie of ELMO-YFP recruitment to sites of attached
anti-ICAM-1 beads on TNF-a-treated MAECs isolated from
SGEF+/+ animals. The arrow indicates the location on an
attaching anti-ICAM-1 bead.
(AVI)
Movie S2 Movie of ELMO-YFP recruitment to sites of attached
anti-ICAM-1 beads on TNF-a-treated MAECs isolated from
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